Want to see TSE:GLOW full AI Analyst Report?
GLOW Stock Chart & Stats
C$0.04
C$0.00(0.00%)
At close: 4:00 PM EDT
C$0.04
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.04 - C$0.07
Previous CloseN/A
Volume19.80K
Average Volume (3M)84.70K
Market Cap
C$7.70M
Enterprise ValueC$7.10
Total Cash (Recent Filing)C$1.60M
Total Debt (Recent Filing)C$34.51K
Price to Earnings (P/E)―
Beta<0.01
Next Earnings
Dec 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding192,435,550
10 Day Avg. Volume9,619
30 Day Avg. Volume84,702
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)3.82
Price to Sales (P/S)5.04
P/FCF Ratio-87.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ScalingRevenue growth indicates improving commercial traction and a broader base of business activity. If this scaling continues, it can provide operating leverage, support reinvestment, and strengthen the company’s ability to progress toward sustainable profitability over the next several quarters.
Narrowing LossesThe substantial reduction in net losses shows that financial performance is moving toward break-even rather than deteriorating. Continued improvement would reduce the funding burden, increase resilience, and create a stronger foundation for eventual positive earnings if revenue keeps expanding.
Low Financial LeverageVery low debt relative to equity limits interest obligations and reduces balance-sheet pressure while the business is still developing. This conservative leverage profile preserves financial flexibility and may allow more capacity to support operations or growth without relying heavily on borrowing.
Bears Say
Negative MarginsNegative net and operating margins show that the current revenue base does not yet cover the company’s operating costs. Until scaling produces stronger efficiency, profitability remains vulnerable to spending levels and the business may require additional capital to sustain expansion.
Ongoing Cash BurnThe company continues to consume cash in both operations and investment, so it is not yet self-funding. Although burn has improved from earlier years, persistent negative cash flow can constrain strategic flexibility and increase dependence on future financing while profitability remains unresolved.
Negative Shareholder ReturnsNegative return on equity indicates that shareholder capital is not currently generating positive returns. This limits the quality of the company’s present earnings profile and highlights that revenue growth and lower losses have not yet translated into efficient, value-generating operations.
Glow LifeTech News
GLOW FAQ
What was Glow LifeTech’s price range in the past 12 months?
Glow LifeTech lowest stock price was C$0.04 and its highest was C$0.07 in the past 12 months.
What is Glow LifeTech’s market cap?
Glow LifeTech’s market cap is C$7.70M.
When is Glow LifeTech’s upcoming earnings report date?
Glow LifeTech’s upcoming earnings report date is Dec 01, 2026 which is in 73 days.
How were Glow LifeTech’s earnings last quarter?
Glow LifeTech released its earnings results on Aug 25, 2026. The company reported -C$0.001 earnings per share for the quarter.
Is Glow LifeTech overvalued?
According to Wall Street analysts Glow LifeTech’s price is currently Overvalued.
Does Glow LifeTech pay dividends?
Glow LifeTech does not currently pay dividends.
What is Glow LifeTech’s EPS estimate?
Glow LifeTech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Glow LifeTech have?
Glow LifeTech has 192,435,550 shares outstanding.
What happened to Glow LifeTech’s price movement after its last earnings report?
Glow LifeTech reported an EPS of -C$0.001 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Glow LifeTech?
Currently, no hedge funds are holding shares in TSE:GLOW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Glow LifeTech
Glow Lifetech Corp. is a biotechnology enterprise based in North America, dedicated to the development and marketing of nutraceutical and cannabinoid-derived products. The company is actively commercializing two core technologies: MyCell Enhanced technology, which facilitates the optimal delivery of nutrients for both nutraceuticals and cannabis, and a Cannabis Smart Consumption System, designed to help users and patients store, track, manage, and consume cannabis products effectively. Glow Lifetech possesses exclusive rights throughout North America for the production, sale, and distribution of a specific micellization technology, applicable to cannabis and hemp-derived ingredients, curcumin, Vitamin K, and iron. A key aspect of their operations involves the advanced processing of ingredients, converting certain vitamins, nutraceuticals, and cannabis extracts into micellized forms. This process significantly boosts the bioavailability of fat-soluble compounds, ensuring near 100% absorption into the body and enhancing their compatibility with water. The company, founded in 2018, is headquartered in Toronto, Canada.
Technical Analysis
COSCIENS Biopharma
―
Kane Biotech
―
Quest Pharmatech
―
PreveCeutical Medical
―
PharmAla Biotech Holdings, Inc.
―